Evropska unija -
slovenščina -
EMA (European Medicines Agency)
ryeqo
gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomyoma - hipofize in hipotalamični hormoni in analogi - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.
Slovenija -
slovenščina -
JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)
unistrain prrs
laboratorios hipra -
Italija -
slovenščina -
Ministero della Salute
spongostan spugna di gelatina emostatica riassorbibile
Italija -
slovenščina -
Ministero della Salute
spongostan spugna di gelatina emostatica riassorbibile
Italija -
slovenščina -
Ministero della Salute
spongostan polvere di gelatina emostatica riassorbibile
Evropska unija -
slovenščina -
EMA (European Medicines Agency)
vidaza
bristol-myers squibb pharma eeig - azacitidin - myelodysplastic syndromes; leukemia, myelomonocytic, chronic; leukemia, myeloid, acute - antineoplastična sredstva - vidaza is indicated for the treatment of adult patients who are not eligible for haematopoietic stem cell transplantation (hsct) with: intermediate 2 and high-risk myelodysplastic syndromes (mds) according to the international prognostic scoring system (ipss),chronic myelomonocytic leukaemia (cmml) with 10 29 % marrow blasts without myeloproliferative disorder,acute myeloid leukaemia (aml) with 20 30 % blasts and multi-lineage dysplasia, according to world health organisation (who) classification. vidaza is indicated for the treatment of adult patients aged 65 years or older who are not eligible for hsct with aml with >30% marrow blasts according to the who classification.